Sds Optic (WAR:SDS) EPS without NRI: zł-0.51 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SDS Sds Optic SA WAR:SDS
22 GF Score
Price zł3.54
! 4 Warning Signs
View Full Analysis

What is Sds Optic EPS without NRI?

Sds Optic WAR:SDS +1.14% 22 EPS without NRI is zł-0.51 as of Mar. 2026. GuruFocus rates WAR:SDS with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 663 Medical Devices & Instruments companies, Sds Optic ranks better than 60.18% on this metric.

Sds Optic's earnings per share without non-recurring items for the three months ended in Mar. 2026 was zł-0.13. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.51.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 16.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -129.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Sds Optic's EPS without NRI or its related term are showing as below:

WAR:SDS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -482.2   Med: -63.1   Max: 16.1
Current: 16.1

During the past 7 years, Sds Optic's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 16.10% per year. The lowest was -482.20% per year. And the median was -63.10% per year.

WAR:SDS's 3-Year EPS without NRI Growth Rate is ranked better than
60.18% of 663 companies
in the Medical Devices & Instruments industry
Industry Median: 8.1 vs WAR:SDS: 16.10

Sds Optic's EPS (Diluted) for the three months ended in Mar. 2026 was zł-0.13. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.51.

Sds Optic's EPS (Basic) for the three months ended in Mar. 2026 was zł-0.13. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.51.


Sds Optic  (WAR:SDS) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sds Optic EPS without NRI Related Terms


Sds Optic EPS without NRI Historical Data

* Premium members only.

The historical data trend for Sds Optic's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sds Optic EPS without NRI Chart

Sds Optic Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -0.18 -0.75 -0.59 -0.78 -0.44

Sds Optic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.19 -0.14 -0.05 -0.13

WAR:SDS vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Sds Optic's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sds Optic PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sds Optic's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Sds Optic's PE Ratio without NRI falls into.


WAR:SDS
22GF Score
Sds Optic SA WAR:SDS
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sds Optic EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of zł-0.51 mean?
Sds Optic (WAR:SDS) has a EPS without NRI of zł-0.51 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sds Optic and its competitors. According to the industry distribution chart, Sds Optic ranks #264 out of 663 companies in the Medical Devices & Instruments industry, placing it in the top 39.8%.
Is Sds Optic's EPS without NRI too high?
Sds Optic's current EPS without NRI is zł-0.51. Based on the distribution chart, Sds Optic ranks #264 out of 663 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sds Optic has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Sds Optic's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sds Optic ranks #264 out of 663 companies for EPS without NRI. This puts Sds Optic in the upper half of its industry. The industry median EPS without NRI is 8.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.10, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sds Optic and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sds Optic's current EPS without NRI is zł-0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sds Optic stock overvalued right now?
Sds Optic (WAR:SDS) has a current EPS without NRI of zł-0.51. The current EPS without NRI is zł-0.51. Sds Optic's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Sds Optic (WAR:SDS), the current EPS without NRI is zł-0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sds Optic Business Description

Address ul. Gleboka 39, Centrum Ecotech-Complex, Block A, Lublin, POL, 20-612
Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.
22GF Score

Get the complete analysis for WAR:SDS

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.54
Price